Article
[Expression of CD19 and CD56 in AML Patients with RUNX1-RUNX1T1 Mutation and Its Clinical Significance].
Zhongguo shi yan xue ye xue za zhi - 1 Jun 2018
Hu Zhong-Li, Zhang Feng, Huang Bao-Jun, Pan Shao-Jun
Abstract excerpt
OBJECTIVE: To investigate the clinical significance of RUNX1-RUNX1T1 expression level in bone marrow of patients with acute non-M3 myeloid leukemia (AML non-M3), and to understand the biological characteristics of RUNX1-RUNX1T1 positive AML expressing lymphoid antigens CD19, CD56 and its effect on the initially induced remission rate and prognosis. METHODS: The expression level of RUNX1-RUNX1T1 in bone marrow of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
